BACKGROUND/AIMS: One of the prognostic methods for survival in primary biliary cirrhosis (PBC) is the Mayo model, with a time-scale limited to 7 years. The aim of our study was to assess how major clinical events, signs, several severity assessment methods and Mayo survival probabilities fit in with actual patient survival, by using yearly observations until 0.5 years before patient death from PBC.METHODOLOGY: Data of 32 patients dying from PBC were collected prior to death at -0.5, -1, -2 etc. years (median: -5 years, range: -16 to -0.5 years). Major events registered were: first occurrence of ascites, upper gastrointestinal bleeding or manifest hepatic encephalopathy and signs, first observation of spider naevi or purpura. Severity assess...
BACKGROUND & AIMS: Approaches to risk stratification for patients with primary biliary cirrhosis (PB...
Background/methods: In 1979 death rate registration for primary biliary cirrhosis (PBC) became avail...
Recent routine testing for liver function and anti-mitochondrial antibodies has increased the number...
BACKGROUND/AIMS: One of the prognostic methods for survival in primary biliary cirrhosis (PBC) is th...
Background & Aims: Although several excellent studies have described the natural history of primary ...
Background/Aims: Estimation of prognosis becomes increasingly important in primary biliary cirrhosis...
Summary: In primary biliary cirrhosis (PBC), clinical events of decompensation are considered indica...
OBJECTIVE: Current prognostic models in primary biliary cirrhosis (PBC) have low precision, partly d...
The progression of primary biliary cirrhosis was studied in 312 patients who were seen at the Mayo C...
Background Current survival models for primary biliary cirrhosis have limited precision for medium a...
BACKGROUND: Current survival models for primary biliary cirrhosis have limited precision for medium ...
Abstract BACKGROUND: The natural history of primary biliary cirrhosis (PBC) is still debated. AIMS:...
INTRODUCTION: Comparative data on scores that predict outcome in primary biliary cholangitis (PBC) a...
SUMMARY We followed up 55 patients with proven primary biliary cirrhosis for several years or until ...
Background: Many patients with primary biliary cirrhosis (PBC) are asymptomatic at the time of diagn...
BACKGROUND & AIMS: Approaches to risk stratification for patients with primary biliary cirrhosis (PB...
Background/methods: In 1979 death rate registration for primary biliary cirrhosis (PBC) became avail...
Recent routine testing for liver function and anti-mitochondrial antibodies has increased the number...
BACKGROUND/AIMS: One of the prognostic methods for survival in primary biliary cirrhosis (PBC) is th...
Background & Aims: Although several excellent studies have described the natural history of primary ...
Background/Aims: Estimation of prognosis becomes increasingly important in primary biliary cirrhosis...
Summary: In primary biliary cirrhosis (PBC), clinical events of decompensation are considered indica...
OBJECTIVE: Current prognostic models in primary biliary cirrhosis (PBC) have low precision, partly d...
The progression of primary biliary cirrhosis was studied in 312 patients who were seen at the Mayo C...
Background Current survival models for primary biliary cirrhosis have limited precision for medium a...
BACKGROUND: Current survival models for primary biliary cirrhosis have limited precision for medium ...
Abstract BACKGROUND: The natural history of primary biliary cirrhosis (PBC) is still debated. AIMS:...
INTRODUCTION: Comparative data on scores that predict outcome in primary biliary cholangitis (PBC) a...
SUMMARY We followed up 55 patients with proven primary biliary cirrhosis for several years or until ...
Background: Many patients with primary biliary cirrhosis (PBC) are asymptomatic at the time of diagn...
BACKGROUND & AIMS: Approaches to risk stratification for patients with primary biliary cirrhosis (PB...
Background/methods: In 1979 death rate registration for primary biliary cirrhosis (PBC) became avail...
Recent routine testing for liver function and anti-mitochondrial antibodies has increased the number...